Surya Mohapatra

Leidos, Inc. provides scientific, engineering, systems integration and technical services and solutions. It offers solutions and services that leverage the power of data analytics, systems integration, and cyber security across national security, health, and engineering markets. The company was founded by John Robert Beyster in June 1969 and is headquartered in Reston, VA.

ITT Corp. manufactures engineered critical components and customized solutions for the energy, transportation, and industrial markets. It operates through the following segments: Industrial Process, Motion Technologies, Interconnect Solutions, and Control Technologies. The Industrial Process segment manufactures engineered fluid process equipment which serves various customers in global infrastructure industries such as oil and gas, mining, power generation, chemical and other process markets and also provides aftermarket services. The Motion Technologies segment manufactures brake pads, shock absorbers, and damping technologies for the global automotive, truck, trailer, and public bus and rail transportation markets. The Interconnect Solutions segment manufactures a wide range of highly specialized connector products that make it possible to transfer signal and power in various electronic devices that are utilized in aerospace and defense; industrial and transportation; oil and gas; and medical markets. The Control Technologies segment manufactures specialized equipment which includes actuation, valves, switches, vibration isolation, custom-energy absorption, and regulators for the aerospace and defense, and industrial markets. The company was founded by Sosthenes Behn and Hernand Behn in 1920 and is headquartered in White Plains, NY.

The Group's principal activities are research and commercialization of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. It's lead product, the Celacade System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade has received European regulatory approval under the CE Mark for chronic heart failure and is currently being marketed in Europe by Grupo Ferrer Internacional, S.A. Celacade is also in late-stage development for the treatment of chronic heart failure in the United States. It is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class.

Quest Diagnostics Clinical Laboratories, Inc. operates testing laboratories. The company was founded on February 17, 1976 and is headquartered in Collegeville, PA.

Part of Cornhill Corp. LLP, Picker International, Inc. is an American company that manufactures heating equipment.

Malaria No More engages in raising awareness and mobilizing public support to end malaria. It provides life-saving bed nets and other critical interventions to families in Africa. The company was founded by Peter Chernin and Raymond G. Chambers in 2006 and is headquartered in Seattle, WA.